Annual Report for the Financial Year 2024-2025

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹16.10

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-1.1% vs market

Healthcare Services peers, median of 53sector · industry level+0.0%-0.6% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 0.6 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6+0.4-1.1+0.0-0.6

Next day

-2.8+0.6-3.4-0.7-2.1

-1.4+1.0-2.4+0.0-1.4

-1.9+0.9-2.8-0.3-1.5

-3.1+0.9-4.0-0.5-2.6

-3.2+1.6-4.9-0.7-2.6

-4.2+2.8-7.1+0.3-4.5

15d

+6.8-2.5+9.3-3.5+10.4

+10.1-1.0+11.1-2.1+12.1

+5.0-0.4+5.4-4.0+9.0

-6.8-7.0+0.2-8.8+2.0

UpDownMarket · Nifty Microcap 250Sector · Healthcare Services peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Globalspace Technologies Ltd has submitted its Annual Report for FY 2024-2025 to BSE as required under Regulation 34(1) of the Listing Regulations. The 15th Annual General Meeting is scheduled for September 29, 2025, at 3:30 PM via video conferencing. The company's key focus areas include its AI-powered healthcare platforms DocExa and MediOla, along with the integrated Innopharm Healthcare acquisition. Key business items at the AGM include reappointment of the Managing Director, appointment of statutory auditors for a 2-year term, appointment of secretarial auditors for 5 years, approval of MD remuneration of ₹48 lakhs per annum, and appointment of a new Independent Director.

Likely market impact

This is a routine regulatory filing of the annual report — no immediate impact on stock price. Shareholders should review the full annual report for financial performance details and note the AGM date for voting on key resolutions including auditor appointments and director remuneration.